Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

BioLife Solutions, Inc. (BLFS)

Nasdaq Health Care Health Care Supplies S&P SmallCap 600
$38.61
+1.31 (+3.51%)
Close of Oct 05, 2026 · end-of-day data
Source: BioLife Solutions, Inc.'s 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 09, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$8.23M$11.02M$19.74M$27.37M$48.09M$119.16M$76.24M$68.02M$74.65M$96.21M
Cost of revenue$3.45M$4.28M$6.22M$8.76M———$26.70M$24.55M$34.10M
Gross profit$4.78M$6.75M$13.53M$18.61M———$41.32M$50.10M$62.12M
Research & development$2.03M$1.19M$1.30M$3.17M$6.72M$11.82M$8.67M$5.51M$4.75M$7.57M
Operating income-$4.85M-$1.06M$3.66M-$220.00K-$6.24M-$35.16M-$5.92M-$17.20M-$4.48M-$16.60M
Interest expense$100.00K$190.00K$5.00K$5.00K——————
Pre-tax income—-$2.52M-$25.00M-$3.20M-$1.28M-$29.03M-$4.85M-$12.22M-$8.82M-$12.08M
Income tax$0$0—-$1.54M-$3.26M-$20.12M-$5.24M-$64.00K-$38.00K$49.00K
Net income-$6.88M-$2.52M-$25.00M-$1.66M$1.98M-$8.91M-$139.81M-$68.00M-$20.18M-$4.59M
EBITDA-$4.48M-$717.00K$4.00M$498.00K-$4.21M-$30.50M$852.00K-$10.09M$683.00K-$14.35M
EPS (basic)$-0.54$-0.21$-1.56$-0.09$0.07$-0.23$-3.29$-1.55$-0.44$-0.09
EPS (diluted)$-0.54$-0.21$-1.56$-0.09$-0.06$-0.23$-3.25$-1.55$-0.44$-0.10
Diluted shares12.64M13.26M21.63M19.46M27.31M38.50M43.07M43.72M46.07M48.65M
Gross margin58.1%61.2%68.5%68.0%———60.7%67.1%64.6%
Operating margin-59.0%-9.6%18.5%-0.8%-13.0%-29.5%-7.8%-25.3%-6.0%-17.3%
Net margin-83.6%-22.8%-126.7%-6.1%4.1%-7.5%-183.4%-100.0%-27.0%-4.8%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$1.41M$6.66M$30.66M$6.45M$90.40M$69.86M$19.44M$27.90M$91.54M$33.04M
Short-term investments$0————$0$43.26M$16.29M$9.20M$55.89M
Receivables$1.19M$1.02M$3.04M$5.34M$8.01M$23.22M$33.94M$7.90M$8.48M$7.95M
Inventory$1.76M$1.85M$3.51M$10.97M$11.60M$28.34M$34.90M$27.16M$29.01M$30.16M
Total current assets$4.63M$9.93M$37.56M$24.11M$114.71M$126.09M$138.45M$120.60M$148.76M$136.56M
Goodwill——$0$33.64M$58.45M$58.45M$224.74M$212.30M$208.59M$208.59M
Total assets$7.93M$12.14M$45.47M$92.82M$234.83M$554.29M$450.23M$412.71M$399.49M$405.88M
Total current liabilities$1.13M$1.51M$1.94M$7.67M$15.57M$42.70M$44.58M$42.18M$32.73M$22.98M
Short-term debt————$614.00K$862.00K$1.81M$6.29M$10.94M$5.00M
Long-term debt$4.25M——$13.00K$655.00K$6.35M$23.79M$17.56M$5.00M$0
Total debt$4.25M——$13.00K$1.27M$7.21M$25.61M$23.85M$15.94M$5.00M
Total liabilities$4.76M$2.05M$30.84M$49.36M$29.58M$76.24M$86.04M$75.05M$50.58M$34.00M
Shareholders' equity$3.17M-$9.53M$14.63M$43.32M$204.43M$478.05M$364.19M$337.66M$348.91M$371.89M

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow-$4.33M$605.00K$2.35M$1.21M$6.64M-$4.59M-$8.49M-$12.50M$8.43M$20.11M
Capital expenditures$143.53K$144.00K$500.00K$675.00K$1.96M$8.38M$10.38M$6.38M$3.23M$9.48M
Free cash flow-$4.47M$461.00K$1.85M$538.00K$4.68M-$12.98M-$18.87M-$18.88M$5.20M$10.64M
Investing cash flow$392.79K-$144.00K-$6.50M-$27.02M-$24.71M-$13.19M-$58.12M$17.84M$58.30M-$71.54M
Financing cash flow$3.17M$4.80M$28.15M$1.60M$102.08M-$2.78M$16.32M$10.59M-$6.78M-$10.92M
Stock-based compensation$776.99K$1.27M$1.52M$3.04M$5.98M$13.96M$25.33M$33.24M$30.92M$22.99M
Depreciation & amortization$368.10K$339.00K$338.00K$718.00K$2.04M$4.66M$6.78M$7.11M$5.16M$2.25M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.